Endothelial dysfunction in the pathogenesis of atherosclerosis

Clinical and Applied Thrombosis/Hemostasis

Volumn 7, Issue 4, 2001, Pages 276-280

  Poredos P ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Atherosclerosis; Endothelial function; Markers of endothelial damage; Vasodilation

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER; CELL ADHESION MOLECULE;

ATHEROSCLEROSIS; ENDOTHELIUM LESION; HUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOSIS; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; ARTERIOSCLEROSIS; BLOOD; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMAL; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; HUMAN; VASODILATION;

EID: 0034775006     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960100700404     Document Type: Review

References (44)

1. Factors involved in the maintenance of endothelial function
2. The pathogenesis of atherosclerosis: A perspective for the 1990s
3. Endothelial dysfunction in human disease
4. The role of endothelium in cardiovascular haemostasis and diseases
5. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
6. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low-density lipoprotein cholesterol levels
7. Relation of blunted dilation of the brachial artery in insulin-dependent diabetes mellitus to microalbuminuria
8. Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension
9. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults
10. Morphological and functional changes of the arterial wall in subjects at risk for atherosclerosis and in patients with peripheral arterial occlusive disease
11. Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction
12. The effect to cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
13. Effect of short term treatment of hyperlipidmia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reserve
14. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension
15. Physical training improves flow-mediated dilation in patients with the polymetabolic syndrome
16. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-Deficient adults
17. Hypercholesterolemia increases endothelial superoxide anion production
18. Vascular smooth muscle nitric oxide synthase anomalies in Dahl/Rapp salt-sensitive rats
19. Endothelial dysfunction: Does it matter? It is reversible?
20. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris
21. Testing for endothelial dysfunction
22. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
23. Coronary vasomotor response to acetylcholine relates to risk factor for coronary artery disease
24. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis
25. Coronary flow reserve is impaired in young men with hypercholesterolemia
26. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
27. Close relationship of endothelial function in the human coronary and peripheral circulations
28. Circulation and tissue endothelin immunoreactivity in advanced atherosclerosis
29. Elevated endothelin-1 levels after cigarette smoking
30. Oxidized low density lipoprotein induce mRNA expression and release of endothelin from human and porcine endothelium
31. Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
32. The PLAT study: Haesmostatic function in relation to atherothrombotic ischemic events in vascular disease patients: Principal results
33. Concentration of endogenous tPA antigen in coronary artery disease. Relation to thrombotic events, aspirin treatment, hyperlipidmia, and multivessel disease
34. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
35. Prospective study of endogenous tissue plasminogen activator and risk of stroke
36. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study
37. Soluble forms of E-selectin. ICAM-1 and VCAM-1 are present in the supernatans of cytokine activated cultured endothelial cell
38. Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction
39. Increased soluble form P-selectin in patients with unstable angina
40. Soluble form of P-selectin in patients with acute myocardial infarction
41. Increased levels of soluble P-selectin in hypercholesterolemic patients
42. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis
43. Plasma concentrations of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men
44. Levels of soluble cell adhesion molecules in patients with dyslipidmia